IMPEL NEUROPHARMA INC's ticker is IMPL and the CUSIP is 45258K109. A total of 36 filers reported holding IMPEL NEUROPHARMA INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $74,053 | -62.4% | 172,218 | +11.1% | 0.00% | – |
| Q2 2023 | $196,799 | -9.0% | 154,960 | +0.4% | 0.00% | – |
| Q1 2023 | $216,146 | +37295.5% | 154,390 | +0.1% | 0.00% | – |
| Q4 2022 | $578 | -99.9% | 154,238 | +3.8% | 0.00% | – |
| Q3 2022 | $723,000 | -32.6% | 148,646 | +29.0% | 0.00% | – |
| Q2 2022 | $1,073,000 | +4.2% | 115,185 | -28.8% | 0.00% | – |
| Q1 2022 | $1,030,000 | -7.3% | 161,789 | +25.6% | 0.00% | – |
| Q4 2021 | $1,111,000 | -22.6% | 128,800 | +9.2% | 0.00% | – |
| Q3 2021 | $1,436,000 | +219.1% | 117,916 | +131.5% | 0.00% | – |
| Q2 2021 | $450,000 | – | 50,942 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 2,884,791 | $24,896,000 | 4.67% |
| venBio Partners LLC | 2,759,791 | $23,817,000 | 4.29% |
| Vivo Capital, LLC | 2,884,789 | $24,896,000 | 1.50% |
| LASRY MARC | 330,000 | $2,848,000 | 1.41% |
| DCF Advisers, LLC | 256,027 | $2,210,000 | 0.90% |
| Kohlberg Kravis Roberts & Co. L.P. | 4,135,971 | $35,693,000 | 0.20% |
| EPIQ PARTNERS, LLC | 18,646 | $161,000 | 0.09% |
| Anson Funds Management LP | 17,729 | $153,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 78,300 | $676,000 | 0.01% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 13,407 | $116,000 | 0.01% |